Brief Research Report

Published on 28 Jun 2023

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety

in Pharmacology of Infectious Diseases

Andrés Ruiz-Sancho
María Núñez-Núñez
Laura Castelo-Corral
Francisco Javier Martínez-Marcos
Nagore Lois-Martínez
Mohd Hafiz Abdul-Aziz
David Vinuesa-García

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185602

4,110 views
7 citations

Systematic Review

Published on 23 Jun 2023

COVID-19 vaccination effectiveness and safety in vulnerable populations: a meta-analysis of 33 observational studies

in Pharmacology of Infectious Diseases

Hui-Jun Li
Qi-Chao Yang
Yang-Yang Yao
Cheng-Yang Huang
Fu-Qiang Yin
Chen-Yang Xian-Yu
Chao Zhang
Shao-Juan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1144824

2,292 views
2 citations

Original Research

Published on 16 Jun 2023

The history of Lyme disease in Italy and its spread in the Italian territory

in Pharmacology of Infectious Diseases

Giusto Trevisan
Maurizio Ruscio
Marina Cinco
Katiuscia Nan
Patrizia Forgione
Nicola Di Meo
Paolo Tranchini
Massimo Nacca
Silvana Trincone
Sara Giordana Rimoldi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128142

6,750 views
5 citations

Editorial

Published on 13 Jun 2023

Editorial: Pharmacology of infectious diseases: world tuberculosis day 2022

in Pharmacology of Infectious Diseases

Shashikant Srivastava
Johannes W. Alffenaar
Sebastian G. Wicha

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1233347

1,360 views
2 citations

Original Research

Published on 12 Jun 2023

Zika virus-like particles (VLPs) produced in insect cells

in Pharmacology of Infectious Diseases

Renata Gois de Mello
Thaissa Consoni Bernardino
Luis Giovani Oliveira Guardalini
Renato Mancini Astray
Marta Maria Antoniazzi
Simone Gonçalves Silva Jared
Eutimio Gustavo Fernández Núñez
Soraia Attie Calil Jorge

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1181566

3,580 views
2 citations

Review

Published on 12 Jun 2023

Bifunctional antibiotic hybrids: A review of clinical candidates

in Pharmacology of Infectious Diseases

Augustine Jing Jie Koh
Varsha Thombare
Maytham Hussein
Gauri G. Rao
Jian Li
Tony Velkov

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1158152

2,863 views
4 citations

Original Research

Published on 07 Jun 2023

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

in Pharmacology of Infectious Diseases

Lei Zhang
Xinfeng Cai
Fangchen Peng
Shuangshuang Tian
Xinjing Wu
Yun Li
Jinlin Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1182644

1,846 views
7 citations

Original Research

Published on 05 Jun 2023

A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir

in Pharmacology of Infectious Diseases

Jiantao Zheng
Wencong Hong
Chanjuan Zhou
Donghuang Hong
Hong Yan
Yanghui Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1146938

2,316 views

Original Research

Published on 30 May 2023

Evaluating the inhibitory effect of resveratrol on the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice

in Pharmacology of Infectious Diseases

Shimaa Abd El-Salam El-Sayed
El-Sayed El-Alfy
Mohamed Z. Sayed-Ahmed
Uday Kumar Mohanta
Saad S. Alqahtani
Nawazish Alam
Sarfaraz Ahmad
Md Sajid Ali
Ikuo Igarashi
Mohamed Abdo Rizk

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192999

2,281 views
2 citations

Original Research

Published on 26 May 2023

Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance

in Pharmacology of Infectious Diseases

Ryunha Kim
Rannissa Puspita Jayanti
Hongyeul Lee
Hyun-Kuk Kim
Jiyeon Kang
I-Nae Park
Jehun Kim
Jee Youn Oh
Hyung Woo Kim
Heayon Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1116226

2,870 views
3 citations

Clinical Trial

Published on 23 May 2023

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study

in Pharmacology of Infectious Diseases

Shanshan Li
Xiaojie Wu
Nanyang Li
Guoying Cao
Jingjing Wang
Yuancheng Chen
Size Li
Jinjie He
Jufang Wu
Haijing Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1117293

2,634 views
2 citations

Mini Review

Published on 18 May 2023

An update on the development of novel antifungal agents for eumycetoma

in Pharmacology of Infectious Diseases

David J. Chandler
Alexandro Bonifaz
Wendy W. J. van de Sande

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1165273

3,210 views
2 citations

Original Research

Published on 16 May 2023

Long-term economic evaluation of the recombinant Mycobacterium tuberculosis fusion protein (EC) test for the diagnosis of Mycobacterium tuberculosis infection

in Pharmacology of Infectious Diseases

Sha Diao
Zheng Liu
Dan Liu
Xiao Cheng
Linan Zeng
Xue-Feng Jiao
Zhe Chen
Xiaofeng Ni
Siyi He
Bin Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1161526

1,879 views
1 citation

Editorial

Published on 15 May 2023

Editorial: Phytochemicals targeting autophagy in treatment of bacterial infection and malignancies

in Pharmacology of Infectious Diseases

Xiaoxue Bai
Lei Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205764

963 views

Review

Published on 05 May 2023

Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis

in Pharmacology of Infectious Diseases

Muhammad Aaqib Shamim
Prakisini Satapathy
Bijaya Kumar Padhi
Sai Dutt Veeramachaneni
Naushaba Akhtar
Anindita Pradhan
Abhimanyu Agrawal
Pradeep Dwivedi
Aroop Mohanty
Keerti Bhusan Pradhan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1149909

7,430 views
5 citations

Review

Published on 05 May 2023

Curtailing virus-induced inflammation in respiratory infections: emerging strategies for therapeutic interventions

in Pharmacology of Infectious Diseases

Alexander A. Globenko
Gennady V. Kuzin
Anastasia V. Rydlovskaya
Elena I. Isaeva
Elizaveta N. Vetrova
Tat’yana N. Pritchina
Ancha Baranova
Vladimir E. Nebolsin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1087850

3,067 views
4 citations

Navigation group

Articles

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety

COVID-19 vaccination effectiveness and safety in vulnerable populations: a meta-analysis of 33 observational studies

The history of Lyme disease in Italy and its spread in the Italian territory

Editorial: Pharmacology of infectious diseases: world tuberculosis day 2022

Zika virus-like particles (VLPs) produced in insect cells

Bifunctional antibiotic hybrids: A review of clinical candidates

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir

Evaluating the inhibitory effect of resveratrol on the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice

Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study

An update on the development of novel antifungal agents for eumycetoma

Long-term economic evaluation of the recombinant Mycobacterium tuberculosis fusion protein (EC) test for the diagnosis of Mycobacterium tuberculosis infection

Editorial: Phytochemicals targeting autophagy in treatment of bacterial infection and malignancies

Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis

Curtailing virus-induced inflammation in respiratory infections: emerging strategies for therapeutic interventions